Quick Takeaways
- SAIF Partners IV L.P. filed SCHEDULE 13D/A for SINOVAC BIOTECH LTD. Common Shares, par value US$0.001 per share (SVA).
- Disclosed ownership: 15%.
- Date of event: 10 Jul 2025.
SAIF Partners IV L.P. - 10 Jul 2025 SCHEDULE 13D/A Report for SINOVAC BIOTECH LTD. Common Shares, par value US$0.001 per share (SVA)
- Filing Manager
- SAIF Partners IV L.P.
- Reporting Manager
- SAIF Partners IV L.P.
- Symbol
- SVA
- Shares outstanding
- 71,872,133 shares
- Disclosed Ownership
- 10,780,820 shares
- Ownership
- 15%
- Form type
- SCHEDULE 13D/A
- Filing time
- 14 Jul 2025, 06:03:50 UTC
- Date of event
- 10 Jul 2025
- Previous filing
- 17 Jun 2025
- Next filing
- 17 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"SAIF Partners IV L.P. disclosed 15% ownership in SINOVAC BIOTECH LTD. Common Shares, par value US$0.001 per share (SVA) on 10 Jul 2025."
What Changed
- Previous schedule filing date: 17 Jun 2025.
- Current filing was accepted on 14 Jul 2025, 06:03.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| SAIF Partners IV L.P. | 15% | 10,780,820 | 10,780,820 | 0 | /s/Andrew Y Yan | Director of SAIF IV GP Capital Ltd., which is the General Partner of SAIF IV GP, L.P., which is the General Partner of SAIF Partners IV L.P. | 0001472789 |
| SAIF IV GP, L.P. | 15% | 10,780,820 | 10,780,820 | 0 | /s/Andrew Y Yan | Director of SAIF IV GP Capital Ltd., which is the General Partner of SAIF IV GP, L.P. | |
| SAIF IV GP Capital Ltd. | 15% | 10,780,820 | 10,780,820 | 0 | /s/Andrew Y Yan | Director of SAIF IV GP Capital Ltd. |